NCT05071404View on ClinicalTrials.gov

Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels.

CompletedOBSERVATIONAL
Enrollment

17

Participants

Timeline

Start Date

November 1, 2020

Primary Completion Date

February 1, 2021

Study Completion Date

February 1, 2021

Conditions
Inflammatory Bowel Diseases
Trial Locations (1)

41009

Hospital Universitario Virgen Macarena, Seville

All Listed Sponsors
lead

Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

OTHER

NCT05071404 - Efficacy Assessment and Monitoring of Subcutaneous Infliximab Levels. | Biotech Hunter | Biotech Hunter